Loading...
XNAS
SGRY
Market cap2.22bUSD
Dec 05, Last price  
17.19USD
1D
-1.09%
1Q
-23.63%
Jan 2017
8.45%
IPO
-6.73%
Name

Surgery Partners Inc

Chart & Performance

D1W1MN
XNAS:SGRY chart
P/E
P/S
0.71
EPS
Div Yield, %
Shrs. gr., 5y
21.17%
Rev. gr., 5y
11.20%
Revenues
3.11b
+13.52%
260,215,000284,599,000403,289,000959,891,0001,145,438,0001,341,219,0001,771,456,0001,831,400,0001,860,100,0002,225,100,0002,539,300,0002,743,300,0003,114,300,000
Net income
-168m
L+1,312.61%
1,916,000-9,062,000-65,897,0001,429,0009,453,000-52,985,000-205,706,00046,100,0001,300,00070,700,00087,000,000-11,900,000-168,100,000
CFO
300m
+2.14%
46,377,00049,078,00021,949,00084,481,000125,239,000120,943,000144,600,000129,500,000246,900,00087,100,000158,800,000293,800,000300,100,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of multi-specialty physician practices, urgent care facilities, and anesthesia services. As of December 31, 2021, it owned or operated a portfolio of 126 surgical facilities, including 108 ambulatory surgical centers and 18 surgical hospitals in 31 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
IPO date
Oct 01, 2015
Employees
9,100
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT